Filter News
Area of Research
News Type
News Topics
- (-) Coronavirus (10)
- (-) Exascale Computing (2)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (8)
- Artificial Intelligence (19)
- Big Data (8)
- Bioenergy (10)
- Biology (9)
- Biomedical (14)
- Biotechnology (2)
- Buildings (2)
- Chemical Sciences (8)
- Clean Water (2)
- Climate Change (5)
- Composites (2)
- Computer Science (32)
- Critical Materials (1)
- Cybersecurity (19)
- Decarbonization (6)
- Energy Storage (12)
- Environment (15)
- Fossil Energy (2)
- Frontier (3)
- Fusion (23)
- Grid (8)
- High-Performance Computing (8)
- Isotopes (1)
- ITER (6)
- Machine Learning (15)
- Materials (16)
- Materials Science (25)
- Mathematics (1)
- Microscopy (4)
- Nanotechnology (12)
- National Security (34)
- Net Zero (1)
- Neutron Science (99)
- Nuclear Energy (33)
- Partnerships (7)
- Physics (11)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (8)
- Security (13)
- Simulation (4)
- Space Exploration (3)
- Summit (7)
- Sustainable Energy (8)
- Transportation (9)
Media Contacts
As renewable sources of energy such as wind and sun power are being increasingly added to the country’s electrical grid, old-fashioned nuclear energy is also being primed for a resurgence.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Laboratory Director Thomas Zacharia presented five Director’s Awards during Saturday night's annual Awards Night event hosted by UT-Battelle, which manages ORNL for the Department of Energy.
When the COVID-19 pandemic stunned the world in 2020, researchers at ORNL wondered how they could extend their support and help
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.